dc.contributor.author
Ferrer-Martínez, Andreu
dc.contributor.author
García Martínez, Celia
dc.contributor.author
Gómez Foix, Anna Maria
dc.date.issued
2025-10-06T18:13:53Z
dc.date.issued
2025-10-06T18:13:53Z
dc.date.issued
2018-09-24
dc.date.issued
2025-10-06T18:13:53Z
dc.identifier
https://hdl.handle.net/2445/223531
dc.description.abstract
E1-deleted recombinant adenoviruses 5 are widely used as gene vectors for
basic and clinical research. Most adenoviral constructions bear an expression
cassette inserted into the E1 region of their genome close to the 5′ end and include a heterologous promoter. The major immediate early human cytomegalovirus (hCMV) and the Rous sarcoma virus promoters, which have fairly high and consistent activity, are among the most extensively used. Nevertheless, expression of delivered protein from these promoters is often excessive, and weaker transcriptional activity would be desirable.
dc.format
application/pdf
dc.publisher
Eaton Pub. Co.]
dc.relation
Reproducció del document publicat a: https://doi.org/10.2144/03343dd02
dc.relation
Biotechniques, 2018, vol. 34, num.3
dc.relation
https://doi.org/10.2144/03343dd02
dc.rights
cc-by (c) Ferrer-Martínez, Andreu et al., 2018
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Citomegalovirus
dc.subject
Cytomegaloviruses
dc.title
Use of adenoviral vectors with a minimal cytomegalovirus promoter
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion